Angion Biomedica (NASDAQ:ANGN) reported quarterly losses of $(0.30) per share. This is a 48.28 percent increase over losses of $(0.58) per share from the same period last year.
BELLUS Health Q2 EPS $(0.23) Down From $(0.14) YoY, Sales $4.00K, Same YoY
BELLUS Health (NASDAQ:BLU) reported quarterly losses of $(0.23) per share. This is a 64.29 percent decrease over losses of $(0.14) per share from the same period last year. The company reported $4.00 thousand in sales
